DEL PRATO, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 48.201
EU - Europa 20.042
AS - Asia 6.191
AF - Africa 281
SA - Sud America 47
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 24
Totale 74.816
Nazione #
US - Stati Uniti d'America 42.272
CA - Canada 5.898
IT - Italia 5.679
PL - Polonia 3.834
CN - Cina 3.431
SE - Svezia 2.694
BG - Bulgaria 2.016
UA - Ucraina 1.377
DE - Germania 1.352
SG - Singapore 875
GB - Regno Unito 827
FI - Finlandia 721
VN - Vietnam 700
CH - Svizzera 633
TR - Turchia 612
HK - Hong Kong 284
RU - Federazione Russa 281
FR - Francia 193
AT - Austria 167
CI - Costa d'Avorio 140
IN - India 116
BE - Belgio 84
SN - Senegal 78
IR - Iran 39
NG - Nigeria 39
IE - Irlanda 37
NL - Olanda 34
IL - Israele 32
BR - Brasile 26
KR - Corea 26
MX - Messico 24
EU - Europa 23
AU - Australia 22
ES - Italia 21
CZ - Repubblica Ceca 17
JP - Giappone 17
GR - Grecia 15
RO - Romania 13
EG - Egitto 9
DK - Danimarca 8
NZ - Nuova Zelanda 8
PT - Portogallo 8
MY - Malesia 6
PK - Pakistan 6
TW - Taiwan 6
BD - Bangladesh 5
CL - Cile 5
HR - Croazia 5
ID - Indonesia 5
IQ - Iraq 5
MA - Marocco 5
NO - Norvegia 5
CO - Colombia 4
EE - Estonia 4
QA - Qatar 4
SC - Seychelles 4
TH - Thailandia 4
AR - Argentina 3
HU - Ungheria 3
KZ - Kazakistan 3
RS - Serbia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
CU - Cuba 2
DZ - Algeria 2
EC - Ecuador 2
GT - Guatemala 2
IS - Islanda 2
JO - Giordania 2
LT - Lituania 2
PA - Panama 2
PE - Perù 2
SA - Arabia Saudita 2
VE - Venezuela 2
A1 - Anonimo 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MD - Moldavia 1
MM - Myanmar 1
MT - Malta 1
NE - Niger 1
NP - Nepal 1
PH - Filippine 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 74.816
Città #
Woodbridge 6.656
Ann Arbor 5.211
Montreal 4.601
Fairfield 4.434
Houston 4.382
Chandler 2.852
Milan 2.307
Ashburn 2.248
Sofia 2.011
Jacksonville 1.995
Seattle 1.810
Wilmington 1.597
Cambridge 1.501
Ottawa 1.251
Beijing 1.160
New York 1.139
Princeton 917
Lawrence 782
Nanjing 712
Medford 673
Bern 628
Izmir 577
Serra 519
Des Moines 477
Singapore 445
Jüchen 350
Dearborn 345
Nanchang 288
San Diego 287
Hong Kong 270
Dong Ket 254
Boulder 252
Rome 198
Redwood City 171
Kunming 165
Vienna 143
Florence 141
Shenyang 141
Abidjan 140
Falls Church 137
Bremen 133
Changsha 122
Ogden 116
Chicago 114
Hebei 113
Pisa 113
London 109
Jiaxing 98
Tianjin 96
Frankfurt am Main 89
Lancaster 86
Grafing 84
Brussels 82
Hefei 79
Washington 79
Dakar 78
Norwalk 75
Los Angeles 64
Boardman 59
Düsseldorf 57
Orange 57
Jinan 55
Hangzhou 54
Auburn Hills 44
Marseille 44
Pune 44
Guangzhou 43
Verona 40
Lagos 35
Warsaw 33
Shanghai 29
Seacroft 28
Phoenix 27
San Francisco 27
Changchun 26
Detroit 26
Indiana 26
Lanzhou 26
Ningbo 26
Zhengzhou 26
Provo 25
Nürnberg 23
Tappahannock 22
Manchester 20
Chengdu 17
Costa Mesa 16
Kocaeli 16
Naples 16
Pasargad 16
Fuzhou 15
Lappeenranta 14
Simi Valley 14
Toronto 14
Redmond 13
Sligo 13
Dublin 12
Mendicino 12
Vicopisano 12
Wuhan 12
Brno 10
Totale 57.041
Nome #
RISULTATI AD UN ANNO NEL TRAPIANTO SIMULTANEO DI PANCREAS-RENE: LA SCELTA PREEMPTIVE E’ VANTAGGIOSA? 4.441
ACE-INHIBITION PROTECTS PANCREATIC HUMAN ISLETS FROM GLUCOTOXICITY AND IMPROVES THE FUNCTION OF ISLETS FROM TYPE 2 DIABETIC PATIENTS 4.096
UN INSOLITO CASO DI IPOGLICEMIA IPERINSULINEMICA DA NESIDIOBLASTOSI E INSULINOMA 358
Gestational diabetes, inflammation, and late vascular disease 184
Q192R PARAOXONASE(PON)1 POLYMORPHISM, INSULIN SENSITIVITY AND ENDOTHELIAL FUNCTION IN ESSENTIAL HYPERTENSIVE MEN 181
G-protein-coupled receptor 40 (GPR40) expression in human pancreatic 174
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 172
Activation of the hexosamine pathway leads to phosphorylation of IRS-1 on Ser307 and Ser612 and impairs the phosphatidylinositol 3-kinase/Akt/mTOR insulin biosynthetic pathway in RIN pancreatic {beta}-cells 170
G-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: The role of type 2 diabetes and fatty acids 168
Dipeptidyl peptidase-4 inhibitors can minimize the hypoglycaemic burden and enhance safety in elderly people with diabetes 164
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial. 164
Absence of islet alpha cell function in pancreatectomized patients. 160
Effects of insulin treatment on ketone body production and carnitine-palmitoyl-transferase (CPT) activity in the isolated perfused liver from streptozotocin diabetic rats. 160
Type 2 diabetes mellitus worsens arterial stiffness in hypertensive patients through endothelial dysfunction. 160
Alpha-Adducin and angiotensin-converting enzyme polymorphisms in hypertension: evidence for a joint influence on albuminuria JOURNAL OF HYPERTENSION JUN 2006 VL 24 IS 6 BP 1217 EP 1217 158
The antiketogenic effect of alanine in normal man: evidence for an alanine-ketone body cycle. 157
Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus 157
Gliclazide potentiates suppression of hepatic glucose production in non-insulin-dependent diabetic patients 155
ACE/AACE consensus conference on the implementation of outpatient management of diabetes mellitus: consensus conference recommendations. 152
Prevalence and risk factors for gestational diabetes assessed by universal screening 152
The contribution of hyperglycaemia and hypoinsulinaemia to the insulin resistance of streptozotocin-diabetic rats 151
A call to action - the UN Resolution on diabetes 151
Metabolic effects of moderate alcohol intake with meals in insulin-dependent diabetics controlled by artificial endocrine pancreas (AEP) and in normal subjects. 149
Body composition study in the elderly: comparison between tritium dilution method and dual photon absorptiometry 149
Pancreas transplant alone (PTA) in type 1 diabetic patients (T1DM): A 3-yr metabolic and diabetic complications follow-up 146
Effect of diabetes on hospitalization for ischemic stroke and related in-hospital mortality. A study in Tuscany, Italy, over years 2004-2011 145
Dissociation of the effects of epinephrine and insulin on glucose and protein metabolism. 145
An off-the-shelf instant contact casting device for the management of diabetic foot ulcers - A randomized prospective trial versus traditional fiberglass cast 143
null 142
Insulin resistance in Cushing's syndrome. 141
Insulin sensitivity, binding, and kinetics in pancreatogenic and type I diabetes 141
Type 2 diabetes mellitus: focus on new treatments and special populations 141
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo 141
Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy 140
What therapy do our NIDDM patients need? Insulin releasers 140
Dipeptidyl peptidase 4 (DPP-4) inhibitors and their role in Type 2 diabetes management 140
Selective screening for GDM in Italy: application and effectiveness of National Guidelines 139
We have the evidence, we need to act to improve diabetes care 139
A Common Polymorphism in the Promoter of UCP2 Contributes to the Variation in Insulin Secretion in Glucose-Tolerant Subjects 139
Functional and survival analysis of isolated human islets 138
ACE gene insertion/deletion polymorphism modulates capillary permeability in hypertension 138
Hyperalaninaemia is an early feature of diabetes secondary to total pancreatectomy. 137
Metabolic control during total parenteral nutrition: use of an artificial endocrine pancreas. 137
Simultaneous pancreas-kidney transplantation is improved by living kidney donation program 136
SINGLE CENTER, OPEN, PROSPECTIVE, RANDOMIZED, PILOT STUDY COMPARING CYCLOSPORINE VERSUS TACROLIMUS IN SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION 135
Fluctuations in glycaemia in clinical diabetes mellitus type 2 are not associated with carotid intima-media thickening. 135
Effect of streptozotocin in a case of glucagon-secreting malignant islets-cell tumor. 134
Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients 133
Glucose transporter 2 gene polymorphisms and beta-cell function in isolated human pancreatic islets 133
The role of peripheral benzodiazepine receptors on the function and survival of isolated human pancreatic islets 133
Hyperglucagonemia and insulin-mediated glucose metabolism 132
Prognostic implications of diabetes phenotyping: new concepts for an old disease 132
The vascular effects of doxazosin in hypertension complicated by metabolic syndrome 132
Portal enteric-drained solitary pancreas transplantation without surveillance biopsy: is it safe? 132
Long-Term (5 Years) Efficacy and Safety of Pancreas Transplantation Alone in Type 1 Diabetic Patients 132
ROLE OF G-PROTEIN-COUPLED RECEPTOR 40 (GPR40) IN NON-DIABETIC AND TYPE 2 DIABETIC PANCREATIC ISLETS. 131
Pathogenetic mechanisms and cardiovascular risk: differences between HbA(1c) and oral glucose tolerance test for the diagnosis of glucose tolerance 131
PPARG2 Pro12Ala and ADAMTS9 rs4607103 as "insulin resistance loci" and "insulin secretion loci" in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4 131
Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes. 130
Optimizing management of metabolic syndrome to reduce the risk: focus on life-style 130
Insulin receptors on circulating blood cells from patients with pancreatogenic diabetes: a comparison with type I diabetes and normal subjects. 129
Retrospective analysis of daily glucose profile in type 1 diabetic patients with continuous subcutaneous insulin infusion (CSII) 129
Successful solitary pancreas transplantation with portal-enteric drainage following unsuccessful islet cell transplantation 129
Gliclazide protects isolated human islets from apoptosis induced by intermittent high glucose: the role of oxidative stress 129
Maternal metabolic control and perinatal outcome in women with gestational diabetes mellitus treated with lispro or aspart insulin: comparison with regular insulin 129
Effect of prolonged overnight fasting on energy metabolism in non-insulin-dependent diabetic and non-diabetic subjects 129
Altered autophagy in the pancreatic beta cells of human type 2 diabetes 129
Gliclazide protects human islet beta-cells from apoptosis induced by intermittent high glucose 129
The presence of retinopathy in patients with secondary diabetes following pancreatectomy or chronic pancreatitis. 128
Beta- and alpha-cell dysfunction in type 2 diabetes 128
Basal insulin and cardiovascular and other outcomes in dysglycemia. 128
1-Hour OGTT Plasma Glucose as a Marker of Progressive Deterioration of Insulin Secretion and Action in Pregnant Women. 128
Mechanisms of fasting hypoglycemia and concomitant insulin resistance in insulinoma patients 127
Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin 127
Elevated non-esterified fatty acids impair nitric oxide independent vasodilation, in humans: evidence for a role of inwardly rectifying potassium channels 126
High insulin levels impair intracellular receptor trafficking in human cultured myoblasts 126
Insulin secretion defects of human type 2 diabetic islets are corrected in vitro by a new reactive oxygen species scavenger. 126
Reconstructing the rate of appearance of subcutaneous insulin by deconvolution. 125
A telemedicine support for diabetes management: the T-IDDM project 125
Cytochrome P450 2J2 polymorphism in healthy Caucasians and those with diabetes mellitus 125
Oxidative stress in isolated human pancreatic islets: possible role of frataxin 125
An alternative and simple method to consistently prepare viable isolated human islets for clinical transplantation 125
Epigenetic regulation of PGC-1 alpha inhuman type 2 diabetic islets and effect on insulin secretion 124
Pancreas transplant alone (PTA) in type 1 diabetic patients (T1DM): a 3-year follow-up 124
Metabolic memory and individual treatment aims in type 2 diabetes--outcome-lessons learned from large clinical trials. 124
The beneficial effects of pancreas transplant alone on diabetic nephropathy 123
PANCREAS TRANSPLANTATION: EFFECTS ON DIABETIC RETINOPATHY 123
Is there a local "incretin system" in human pancreatic islets? 123
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events. A randomized controlled trial. 123
C-reactive protein and metabolic syndrome in women with previous gestational diabetes 123
Insulin Resistance and Lipid Disorders 123
Durability of the efficacy and safety of alogliptin compared with glipizide in type 2 diabetes mellitus: a 2-year study. 123
The relationship between alanine and ketone body in vivo 122
Role of tissue specific blood flow and tissue recruitment in insulin-mediated glucose uptake of human skeletal muscle 122
Effects of prolonged in vitro exposure to sulphonylureas on the function and survival of human islets 122
Ninety-five percent insulin independence rate 3 years after pancreas transplantation alone with portal-enteric drainage 122
Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: A 10-year follow-up study 122
Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes 121
Is maternal educational level a risk factor for gestational diabetes in Caucasian women? 121
Cystatin C as a marker of renal function immediately after liver transplantation. 121
Totale 22.214
Categoria #
all - tutte 180.259
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 180.259


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202012.379 1.597 1.208 626 759 1.235 1.210 1.360 995 1.405 724 1.054 206
2020/20216.203 679 272 563 257 615 269 572 598 594 495 335 954
2021/20228.379 241 610 186 543 1.596 1.183 213 441 297 302 462 2.305
2022/20237.982 1.152 730 381 800 1.086 1.161 86 685 1.253 84 470 94
2023/202416.715 1.376 1.129 1.122 568 1.230 1.295 172 192 162 8.525 152 792
2024/2025116 116 0 0 0 0 0 0 0 0 0 0 0
Totale 75.653